(NYSE: COR) Cencora's forecast annual revenue growth rate of 6.08% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.87%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.2%.
Cencora's revenue in 2025 is $310,232,192,000.On average, 6 Wall Street analysts forecast COR's revenue for 2025 to be $62,469,066,223,977, with the lowest COR revenue forecast at $61,856,621,606,813, and the highest COR revenue forecast at $63,068,054,839,379. On average, 6 Wall Street analysts forecast COR's revenue for 2026 to be $67,039,812,275,881, with the lowest COR revenue forecast at $65,850,618,737,861, and the highest COR revenue forecast at $67,792,245,518,884.
In 2027, COR is forecast to generate $71,809,474,720,730 in revenue, with the lowest revenue forecast at $69,694,545,514,394 and the highest revenue forecast at $72,869,161,025,618.